In a new research paper, Northeastern faculty members discuss the analytical challenges researchers face as biosimilars take center stage in pharmaceutical development.
Northeastern University hosted a ribbon-cutting ceremony on Wednesday to commemorate the new home of the Waters Laboratory at 140 The Fenway. The lab, designated as a Waters Center of Innovation, … read more »
Northeastern and the Dana-Farber Cancer Institute have announced an institutional collaboration to fight cancer by leveraging each institution’s expertise.
Northeastern professor John R. Engen is part of an interdisciplinary, multi-institutional research team that recently published a paper on HIV antibodies in the journal Nature Structural & Molecular Biology.
Chemistry chair’s testimony at FDA hearing advances University’s role in formulating U.S. approach to introduction of new biopharmaceuticals
Chemistry major coauthors paper on cancer treatment in Nature magazine and earns plaudits from his research mentor at Dana-Farber Cancer Institute
Chemistry professor is advancing novel methods for analyzing a specific family of proteins that play a key role in the creation of new biopharmaceuticals
Northeastern professor John Engen has been recognized by the ACS for his achievements and research contributions as a young analytical scientist.
(with Kim, M., Sun, Z.-Y. J., Rand, K. D., Shi, X., Song, L., Cheng, Y., Fahmy, A. F., Majumdar, S., Ofek, G., Yang, Y., Kwong, P. D., Wang, J.-H., Wagner, G. & Reinherz, E. L. ) Nat. Struct. Mol. Biol. 18(11), 1235-1243.
(with Morgan, C. R., Hebling, C. M., Rand, K. D., Stafford, D. W., and Jorgenson, J. W.) Mol. Cell. Proteomics 10(9), M111.010876.
(with Marcsisin, S. R., Narute, P. S., Emert-Sedlak, L. A., Kloczewiak, M., and Smithgall, T. E.) J. Mol. Biol. 410(5), 1008-1022.